Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.
about
The expression of VEGF-A is down regulated in peripheral blood mononuclear cells of patients with secondary progressive multiple sclerosisX-Ray Phase Contrast Tomography Reveals Early Vascular Alterations and Neuronal Loss in a Multiple Sclerosis Model.Vascular pathology in multiple sclerosis: mind boosting or myth busting?Pathogenic implications of iron accumulation in multiple sclerosis.Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.Extensive vascular remodeling in the spinal cord of pre-symptomatic experimental autoimmune encephalomyelitis mice; increased vessel expression of fibronectin and the α5β1 integrin.The role of angiogenesis in the pathology of multiple sclerosis.Transcriptome sequencing reveals differences between primary and secondary hair follicle-derived dermal papilla cells of the Cashmere goat (Capra hircus).Murine experimental autoimmune encephalomyelitis is diminished by treatment with the angiogenesis inhibitors B20-4.1.1 and angiostatin (K1-3)Soluble VCAM-1 impairs human brain endothelial barrier integrity via integrin α-4-transduced outside-in signalling.Inhibition of Vascular Endothelial Growth Factor Receptor 2 Exacerbates Loss of Lower Motor Neurons and Axons during Experimental Autoimmune Encephalomyelitis.Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophenUpregulation of vascular endothelial growth factor receptor-3 in the spinal cord of Lewis rats with experimental autoimmune encephalomyelitisTNF-α promotes cerebral pericyte remodeling in vitro, via a switch from α1 to α2 integrins.Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells.How do immune cells overcome the blood-brain barrier in multiple sclerosis?Receptor Tyrosine Kinase and Tyrosine Kinase Inhibitors: New Hope for Success in Multiple Sclerosis TherapyBlood-brain barrier-supported neurogenesis in healthy and diseased brain.Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.Integrative Analysis of mRNA, microRNA, and Protein Correlates of Relative Cerebral Blood Volume Values in GBM Reveals the Role for Modulators of Angiogenesis and Tumor Proliferation.Bevacizumab diminishes experimental autoimmune encephalomyelitis by inhibiting spinal cord angiogenesis and reducing peripheral T-cell responses.Endothelial α6β4 integrin protects during experimental autoimmune encephalomyelitis-induced neuroinflammation by maintaining vascular integrity and tight junction protein expression.Vascular endothelial growth factor-A mRNA gene expression in clinical phases of multiple sclerosis.Microglial interactions with the neurovascular system in physiology and pathology.N-tert-butyloxycarbonyl-Phe-Leu-Phe-Leu-Phe (BOC2) inhibits the angiogenic activity of heparin-binding growth factors.Hypoxic pre-conditioning suppresses experimental autoimmune encephalomyelitis by modifying multiple properties of blood vessels
P2860
Q28740407-77B2C235-3B0D-4AE1-96DB-94D88E330C93Q33919133-D642FE6E-E92C-4EBA-A863-12D062CC3F7EQ33960741-F9FDEA8C-3142-4147-BF83-A404C49BD0A9Q34049616-3BF59DBE-C9C3-4A91-8DE2-2242311EB731Q34109028-F6B646E6-E76D-4C49-A29C-C9665F04E639Q34532833-9A7A164F-F37E-49B9-8C25-2C10AEA44B6BQ34620249-A41388C3-80B5-4B2F-8E82-0A83D42E45BDQ34999770-71108894-4590-41E3-B3FF-C36E17F9CC7DQ35108066-7EBE2931-CFA0-40DA-ABB3-69F7DEDF9414Q35512654-0440F0EC-206E-4E5F-923A-FD622F76F62AQ36088247-8280EFA0-4F5A-4B47-A6BB-30D8C4E68CEDQ36354157-9E4C468D-CA09-48C3-9ABE-263307A82D92Q36500155-51DCA2D8-6E6E-4493-969B-90378408CFE7Q36741459-13DF6AC6-A875-403F-A6B8-FD53A8A56120Q37365857-3F468FD4-1906-4E2A-B9A2-1B52278E7740Q37873072-79A2E8B2-82E5-4561-AF3A-B28C9E705881Q38261946-1D96D1DF-6EE3-4D3E-AB75-B136E0CC3F92Q38757773-A5515AA7-4D0A-46A3-AC14-D42D2BA43478Q39479822-BCC058A4-D95D-4830-9943-238D5AB303ECQ39692548-08DE6AF6-91B4-4F61-8C76-ABC1D859FCEDQ44916496-A58B3C3D-E9D2-4454-86BF-6526E64928D6Q45188146-3963499A-8573-4A94-82C0-C80AA86E5109Q46163647-38BCFF2C-BC1D-445D-970F-1E93E460B97AQ47741460-3F35FA66-6B6D-4D4C-A6B4-9D721092F3BDQ47797389-53ADB223-D76C-4E61-AB82-796767260E92Q58768157-6FD8C3C5-3A05-4F0A-80EB-D83D37B87F50
P2860
Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@ast
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@en
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@nl
type
label
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@ast
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@en
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@nl
prefLabel
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@ast
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@en
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@nl
P2093
P2860
P356
P1476
Angiogenesis is present in exp ...... in multiple sclerosis lesions.
@en
P2093
Amanda Littlewood-Evans
Bernadette Pöllinger
Christian Schnell
Peter C Hiestand
Timothy J Seabrook
Volker Brinkmann
P2860
P2888
P356
10.1186/1742-2094-7-95
P577
2010-12-22T00:00:00Z
P5875
P6179
1046969309